SCHEMBL2990191

SCHEMBL2990191

O=Cc1ccc(Oc2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)c(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
GAA P10253 2/20 0.50
PPARA Q07869 2/20 0.50
ALDH1A1 P00352 1/20 0.50
FABP2 P12104 1/20 0.50
PPARG P37231 1/20 0.50
PPARD Q03181 1/20 0.50
PTGDR2 Q9Y5Y4 9/20 0.49
NPC1 O15118 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C19 P33261 1/20 0.48
RAB9A P51151 1/20 0.48
GFER P55789 1/20 0.48
TRPV1 Q8NER1 3/20 0.48
CCR2 P41597 2/20 0.46
MCHR1 Q99705 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986649 0.85 PPARA (0.53) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2991888 0.85 GAA (0.53) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2990144 0.83 SMN1; SMN2 (0.49) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2989859 0.83 PPARA (0.44) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2989862 0.83 PPARA (0.44) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2989864 0.83 PPARA (0.44) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2987661 0.82 PTGDR2 (0.64) GAAPTGDR2
SCHEMBL3697026 0.74 PARP10 (0.60) SMN1; SMN2ALDH1A1MAPT
SCHEMBL2988631 0.74 GAA (0.54) SMN1; SMN2GAAPPARAALDH1A1FABP2
SCHEMBL2982709 0.74 PTGDR2 (0.60) SMN1; SMN2GAAPPARAALDH1A1FABP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 SMN1; SMN2 3361/4885GAA 2523/4885PPARA 874/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 SMN1; SMN2 3361/4885GAA 2523/4885PPARA 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.